{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:47:52Z","timestamp":1792594072928,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00393-020-00915-y","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T15:02:37Z","timestamp":1604415757000},"page":"1009-1017","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Diagnostik, Therapie und Prophylaxe des Herpes zoster","Diagnosis, treatment and prophylaxis of herpes zoster"],"prefix":"10.1007","volume":"79","author":[{"given":"Boris","family":"Ehrenstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,3]]},"reference":[{"key":"915_CR1","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1097\/INF.0b013e3181a90b16","volume":"28","author":"R Civen","year":"2009","unstructured":"Civen\u00a0R, Chaves\u00a0SS, Jumaan\u00a0A et\u00a0al (2009) The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis\u00a0J 28:954\u2013959","journal-title":"Pediatr Infect Dis J"},{"key":"915_CR2","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1177\/0883073818821498","volume":"34","author":"A Moodley","year":"2019","unstructured":"Moodley\u00a0A, Swanson\u00a0J, Grose\u00a0C et\u00a0al (2019) Severe herpes zoster following varicella vaccination in immunocompetent young children. J\u00a0Child Neurol 34:184\u2013188","journal-title":"J Child Neurol"},{"key":"915_CR3","first-page":"391","volume":"36","author":"Anonymous","year":"2017","unstructured":"Anonymous (2017) St\u00e4ndige Impfkommission (STIKO): Wissenschaftliche Begr\u00fcndung f\u00fcr die Entscheidung, die Herpes zoster Lebendimpfung nicht als Standardimpfung zu empfehlen. Epidemiol Bull 36:391\u2013411","journal-title":"Epidemiol Bull"},{"key":"915_CR4","volume-title":"AWMF S2k-Leitlinie \u201eDiagnostik und Therapie des Zoster und der Postzosterneuralgie\u201c","author":"GE Gross","year":"2019","unstructured":"Gross\u00a0GE (2019) AWMF S2k-Leitlinie \u201eDiagnostik und Therapie des Zoster und der Postzosterneuralgie\u201c"},{"key":"915_CR5","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1159\/000024949","volume":"41","author":"W Meister","year":"1998","unstructured":"Meister\u00a0W, Neiss\u00a0A, Gross\u00a0G et al (1998) Demography, symptomatology, and course of disease in ambulatory zoster patients. A physician-based survey in Germany. Intervirology 41:272\u2013277","journal-title":"Intervirology"},{"issue":"1","key":"915_CR6","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1002\/jmv.10364","volume":"70","author":"PE Kilgore","year":"2003","unstructured":"Kilgore\u00a0PE, Kruszon-Moran\u00a0D, Seward\u00a0JF et al (2003) Varicella in Americans from NHANES III: implications for control through routine immunization. J\u00a0Med Virol 70(1):S111\u2013118","journal-title":"J Med Virol"},{"key":"915_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1017\/S0950268801005921","volume":"127","author":"M Brisson","year":"2001","unstructured":"Brisson\u00a0M, Edmunds\u00a0WJ, Law\u00a0B et\u00a0al (2001) Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 127:305\u2013314","journal-title":"Epidemiol Infect"},{"key":"915_CR8","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jinf.2014.08.018","volume":"70","author":"K Hillebrand","year":"2015","unstructured":"Hillebrand\u00a0K, Bricout\u00a0H, Schulze-Rath\u00a0R et al (2015) Incidence of herpes zoster and its complications in Germany, 2005\u20132009. J\u00a0Infect 70:178\u2013186","journal-title":"J Infect"},{"key":"915_CR9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1471-2334-11-173","volume":"11","author":"B Ultsch","year":"2011","unstructured":"Ultsch\u00a0B, Siedler\u00a0A, Rieck\u00a0T et\u00a0al (2011) Herpes zoster in Germany: quantifying the burden of disease. BMC Infect Dis 11:173","journal-title":"BMC Infect Dis"},{"key":"915_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4065\/mcp.2010.0618","volume":"86","author":"BP Yawn","year":"2011","unstructured":"Yawn\u00a0BP, Wollan\u00a0PC, Kurland\u00a0MJ et\u00a0al (2011) Herpes zoster recurrences more frequent than previously reported. Mayo Clin Proc 86:88\u201393","journal-title":"Mayo Clin Proc"},{"key":"915_CR11","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1097\/INF.0000000000001249","volume":"35","author":"R Civen","year":"2016","unstructured":"Civen\u00a0R, Marin\u00a0M, Zhang\u00a0J et\u00a0al (2016) Update on incidence of herpes zoster among children and adolescents after implementation of varicella vaccination, Antelope Valley, CA, 2000 to 2010. Pediatr Infect Dis\u00a0J 35:1132\u20131136","journal-title":"Pediatr Infect Dis J"},{"key":"915_CR12","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1080\/21645515.2018.1446718","volume":"14","author":"B Zoch-Lesniak","year":"2018","unstructured":"Zoch-Lesniak\u00a0B, Tolksdorf\u00a0K, Siedler\u00a0A (2018) Trends in herpes zoster epidemiology in Germany based on primary care sentinel surveillance data, 2005\u20132016. Hum Vaccin Immunother 14:1807\u20131814","journal-title":"Hum Vaccin Immunother"},{"key":"915_CR13","doi-asserted-by":"publisher","first-page":"g2911","DOI":"10.1136\/bmj.g2911","volume":"348","author":"HJ Forbes","year":"2014","unstructured":"Forbes\u00a0HJ, Bhaskaran\u00a0K, Thomas\u00a0SL et al (2014) Quantification of risk factors for herpes zoster: population based case-control study. BMJ 348:g2911","journal-title":"BMJ"},{"key":"915_CR14","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1590\/S1807-59322011000700009","volume":"66","author":"HH Chen","year":"2011","unstructured":"Chen\u00a0HH, Chen\u00a0YM, Chen\u00a0TJ et al (2011) Risk of herpes zoster in patients with systemic lupus erythematosus: a\u00a0three-year follow-up study using a\u00a0nationwide population-based cohort. Clinics (Sao Paulo) 66:1177\u20131182","journal-title":"Clinics (Sao Paulo)"},{"key":"915_CR15","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1177\/0961203315627203","volume":"25","author":"JC Ferreira","year":"2016","unstructured":"Ferreira\u00a0JC, Marques\u00a0HH, Ferriani\u00a0MP et al (2016) Herpes zoster infection in childhood-onset systemic lupus erythematosus patients: a\u00a0large multicenter study. Lupus 25:754\u2013759","journal-title":"Lupus"},{"key":"915_CR16","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1136\/annrheumdis-2020-217207","volume":"79","author":"A Strangfeld","year":"2020","unstructured":"Strangfeld\u00a0A, Redeker\u00a0I, Kekow\u00a0J et\u00a0al (2020) OP0238: risk of herpes zoster in patients with rheumatoid arthritis under biological, targeted synthetic and conventional syntetic DMARD treatment. Ann Rheum Dis 79:150","journal-title":"Ann Rheum Dis"},{"key":"915_CR17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/BF02770836","volume":"26","author":"W Meister","year":"1998","unstructured":"Meister\u00a0W, Neiss\u00a0A, Gross\u00a0G et\u00a0al (1998) A prognostic score for postherpetic neuralgia in ambulatory patients. Infection 26:359\u2013363","journal-title":"Infection"},{"key":"915_CR18","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman\u00a0MN, Levin\u00a0MJ, Johnson\u00a0GR et\u00a0al (2005) A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N\u00a0Engl J Med 352:2271\u20132284","journal-title":"N Engl J Med"},{"issue":"17","key":"915_CR19","doi-asserted-by":"publisher","first-page":"30521","DOI":"10.2807\/1560-7917.ES.2017.22.17.30521","volume":"22","author":"T Rieck","year":"2017","unstructured":"Rieck\u00a0T, Feig\u00a0M, An der Heiden\u00a0M et\u00a0al (2017) Assessing varicella vaccine effectiveness and its influencing factors using health insurance claims data, Germany, 2006 to 2015. Euro Surveill 22(17):30521. https:\/\/doi.org\/10.2807\/1560-7917.ES.2017.22.17.30521","journal-title":"Euro Surveill"},{"key":"915_CR20","first-page":"541","volume":"50","author":"Anonymous","year":"2018","unstructured":"Anonymous (2018) St\u00e4ndige Impfkommission (STIKO): Wissenschaftliche Begr\u00fcndung zur Empfehlung einer Impfung mit dem Herpes zoster-subunit-Totimpfstoff. Epidemiol Bull 50:541\u2013567","journal-title":"Epidemiol Bull"},{"key":"915_CR21","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","volume":"375","author":"AL Cunningham","year":"2016","unstructured":"Cunningham\u00a0AL, Lal\u00a0H, Kovac\u00a0M et\u00a0al (2016) Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N\u00a0Engl J Med 375:1019\u20131032","journal-title":"N Engl J Med"},{"key":"915_CR22","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"H Lal","year":"2015","unstructured":"Lal\u00a0H, Cunningham\u00a0AL, Godeaux\u00a0O et\u00a0al (2015) Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N\u00a0Engl J Med 372:2087\u20132096","journal-title":"N Engl J Med"},{"key":"915_CR23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S1090-3801(02)00046-0","volume":"6","author":"P H\u00fcgler","year":"2002","unstructured":"H\u00fcgler\u00a0P, Siebrecht\u00a0P, Hoffmann\u00a0K et al (2002) Prevention of postherpetic neuralgia with varicella-zoster hyperimmune globulin. Eur J Pain 6:435\u2013445","journal-title":"Eur J Pain"},{"key":"915_CR24","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s00103-019-02905-1","volume":"62","author":"N Wagner","year":"2019","unstructured":"Wagner\u00a0N, Assmus\u00a0F, Arendt\u00a0G et\u00a0al (2019) Impfen bei Immundefizienz. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 62:494\u2013515","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"915_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1001\/jama.2019.9053","volume":"322","author":"A Bastidas","year":"2019","unstructured":"Bastidas\u00a0A, de la Serna\u00a0J, El Idrissi\u00a0M et\u00a0al (2019) Effect of recombinant zoster vaccine on incidence of herpes zoster after autologous stem cell transplantation: a randomized clinical trial. JAMA 322:123\u2013133","journal-title":"JAMA"},{"key":"915_CR26","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/infdis\/jiu606","volume":"211","author":"EM Berkowitz","year":"2015","unstructured":"Berkowitz\u00a0EM, Moyle\u00a0G, Stellbrink\u00a0HJ et al (2015) Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a\u00a0phase 1\/2a randomized, placebo-controlled study. J\u00a0Infect Dis 211:1279\u20131287","journal-title":"J Infect Dis"},{"key":"915_CR27","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/S1473-3099(19)30163-X","volume":"19","author":"AF Dagnew","year":"2019","unstructured":"Dagnew\u00a0AF, Ilhan\u00a0O, Lee\u00a0WS et al (2019) Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a\u00a0phase 3, randomised, clinical trial and post-hoc efficacy analysis. Lancet Infect Dis 19:988\u20131000","journal-title":"Lancet Infect Dis"},{"key":"915_CR28","first-page":"181","volume":"70","author":"P Vink","year":"2020","unstructured":"Vink\u00a0P, Torrell\u00a0JMR, Sanchez Fructuoso\u00a0A et\u00a0al (2020) Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in chronically immunosuppressed adults following renal transplant: a phase 3, randomized clinical trial. Clin Infect Dis 70:181\u2013190","journal-title":"Clin Infect Dis"},{"key":"915_CR29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/acr2.11150","volume":"2","author":"E Stevens","year":"2020","unstructured":"Stevens\u00a0E, Weinblatt\u00a0ME, Massarotti\u00a0E et\u00a0al (2020) Safety of the zoster vaccine recombinant adjuvanted in rheumatoid arthritis and other systemic rheumatic disease patients: a single center\u2019s experience with 400 patients. ACR Open Rheumatol 2:357\u2013361","journal-title":"ACR Open Rheumatol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-020-00915-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-020-00915-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-020-00915-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T10:52:10Z","timestamp":1606819930000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-020-00915-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,3]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["915"],"URL":"https:\/\/doi.org\/10.1007\/s00393-020-00915-y","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,3]]},"assertion":[{"value":"3 November 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>B.\u00a0Ehrenstein<\/b>: A.\u00a0Finanzielle Interessen: Keine passive Teilnahme an firmenfinanzierten Fortbildungsveranstaltungen, erhaltene Vortragshonorare (2014\u20132019): Bayerischer Haus\u00e4rzte Verband, Patientenorganisation f\u00fcr angeborene Immundefekte (DSAI), AbbVie, Berlin-Chemie, BMS, Janssen, Medac, Novartis, Pfizer, Roche, Sanofi, MSD, UCB. \u2013 B.\u00a0Nichtfinanzielle Interessen: Oberarzt in rheumatologischer Fachklinik | Mitgliedschaft: Gesellschaft f\u00fcr Rheumatologie.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}